# A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants

> **NCT00192348** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 120 (—)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** CAIV-T

## Key facts

- **NCT ID:** NCT00192348
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** 120 (—)
- **Last updated:** 2021-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192348, "A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00192348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*